These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38206448)
1. Treatment of cartilage defects in the patellofemoral joint with matrix-associated autologous chondrocyte implantation effectively improves pain, function, and radiological outcomes after 5-7 years. Eichinger M; Henninger B; Petry B; Schuster P; Herbst E; Wagner M; Rosenberger R; Mayr R Arch Orthop Trauma Surg; 2024 Apr; 144(4):1655-1665. PubMed ID: 38206448 [TBL] [Abstract][Full Text] [Related]
2. A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation. Ebert JR; Schneider A; Fallon M; Wood DJ; Janes GC Am J Sports Med; 2017 Dec; 45(14):3243-3253. PubMed ID: 28910133 [TBL] [Abstract][Full Text] [Related]
3. Clinical and Radiological Outcomes at ≥10-Year Follow-up After Matrix-induced Autologous Chondrocyte Implantation in the Patellofemoral Joint. Ebert JR; Klinken S; Fallon M; Wood DJ; Janes GC Am J Sports Med; 2024 Aug; 52(10):2532-2540. PubMed ID: 39101611 [TBL] [Abstract][Full Text] [Related]
4. 10-Year Prospective Clinical and Radiological Evaluation After Matrix-Induced Autologous Chondrocyte Implantation and Comparison of Tibiofemoral and Patellofemoral Graft Outcomes. Ebert JR; Zheng M; Fallon M; Wood DJ; Janes GC Am J Sports Med; 2024 Mar; 52(4):977-986. PubMed ID: 38384192 [TBL] [Abstract][Full Text] [Related]
5. Management of patellar and trochlear cartilage lesions with matrix-induced autologous chondrocyte implantation in conjunction with patellofemoral realignment procedures improves patient-reported outcomes and magnetic resonance image appearance. Retzky JS; Carey EG; Selley RS; Fletcher C; Hartwell MJ; Burge AJ; Gomoll A; Strickland S J ISAKOS; 2024 Oct; 9(5):100311. PubMed ID: 39154863 [TBL] [Abstract][Full Text] [Related]
6. Prospective Long-term Follow-up of Autologous Chondrocyte Implantation With Periosteum Versus Matrix-Associated Autologous Chondrocyte Implantation: A Randomized Clinical Trial. Barié A; Kruck P; Sorbi R; Rehnitz C; Oberle D; Walker T; Zeifang F; Moradi B Am J Sports Med; 2020 Jul; 48(9):2230-2241. PubMed ID: 32667270 [TBL] [Abstract][Full Text] [Related]
7. Prospective clinical and radiologic evaluation of patellofemoral matrix-induced autologous chondrocyte implantation. Ebert JR; Fallon M; Smith A; Janes GC; Wood DJ Am J Sports Med; 2015 Jun; 43(6):1362-72. PubMed ID: 25784629 [TBL] [Abstract][Full Text] [Related]
8. Mid- to Long-Term Clinical Outcomes of Cartilage Restoration of Knee Joint with Allogenic Next-Generation Matrix-Induced Autologous Chondrocyte Implantation (MACI). Liu Y; Ma N; Zhao Z; Guo Q Orthop Surg; 2023 Feb; 15(2):549-562. PubMed ID: 36650102 [TBL] [Abstract][Full Text] [Related]
9. Matrix-induced autologous chondrocyte implantation (MACI) for chondral defects in the patellofemoral joint. Meyerkort D; Ebert JR; Ackland TR; Robertson WB; Fallon M; Zheng MH; Wood DJ Knee Surg Sports Traumatol Arthrosc; 2014 Oct; 22(10):2522-30. PubMed ID: 24817164 [TBL] [Abstract][Full Text] [Related]
10. Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects. Marlovits S; Aldrian S; Wondrasch B; Zak L; Albrecht C; Welsch G; Trattnig S Am J Sports Med; 2012 Oct; 40(10):2273-80. PubMed ID: 22922521 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after first-generation autologous chondrocyte implantation for cartilage defects of the knee. Niemeyer P; Porichis S; Steinwachs M; Erggelet C; Kreuz PC; Schmal H; Uhl M; Ghanem N; Südkamp NP; Salzmann G Am J Sports Med; 2014 Jan; 42(1):150-7. PubMed ID: 24145948 [TBL] [Abstract][Full Text] [Related]
12. Results 2 Years After Matrix-Associated Autologous Chondrocyte Transplantation Using the Novocart 3D Scaffold: An Analysis of Clinical and Radiological Data. Zak L; Albrecht C; Wondrasch B; Widhalm H; Vekszler G; Trattnig S; Marlovits S; Aldrian S Am J Sports Med; 2014 Jul; 42(7):1618-27. PubMed ID: 24817007 [TBL] [Abstract][Full Text] [Related]
13. Arthroscopic gel-type autologous chondrocyte implantation presents histologic evidence of regenerating hyaline-like cartilage in the knee with articular cartilage defect. Yoon TH; Jung M; Choi CH; Kim HS; Lee YH; Choi YS; Kim SJ; Kim SH Knee Surg Sports Traumatol Arthrosc; 2020 Mar; 28(3):941-951. PubMed ID: 31240378 [TBL] [Abstract][Full Text] [Related]
14. Correlation Between Clinical and Radiological Outcomes After Matrix-Induced Autologous Chondrocyte Implantation in the Femoral Condyles. Ebert JR; Smith A; Fallon M; Wood DJ; Ackland TR Am J Sports Med; 2014 Aug; 42(8):1857-64. PubMed ID: 24890782 [TBL] [Abstract][Full Text] [Related]
15. A Prospective Clinical and Radiological Evaluation at 5 Years After Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation. Ebert JR; Fallon M; Wood DJ; Janes GC Am J Sports Med; 2017 Jan; 45(1):59-69. PubMed ID: 27587741 [TBL] [Abstract][Full Text] [Related]
16. Autologous chondrocyte implantation in the patella: a multicenter experience. Gomoll AH; Gillogly SD; Cole BJ; Farr J; Arnold R; Hussey K; Minas T Am J Sports Med; 2014 May; 42(5):1074-81. PubMed ID: 24595400 [TBL] [Abstract][Full Text] [Related]